Abramowski MC. Chemotherapy-Induced Neuropathic Pain. J of the Advanced Practitioner in Oncology. 2010;1:279-283.
Biedrzycki BA. Peripheral Neuropathy. In Brown CG (Ed) A Guide to Oncology Symptom Management. 2010; Oncology Nursing Society, Pittsburgh: 405-421.
Bringhen S, Larocca A, Rossi D, et al. Efficacy and safety of once-weekly bortezomib in multiple myeloma patients. Blood. 2010;116(23):4745-4753.
Coyle N, Silver J, Meuche G, Messner C. Understanding Peripheral Neuropathy. CancerCare booklet edited and produced by Elsevier Oncology. 2008.
del Pino BM. Chemotherapy-Induced Peripheral Neuropathy. NCI Ca Bull. 2010;7:6. Accessed at www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/022310/page6 on December 16, 2011.
Gamelin L, et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: A retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res. 2004;10:4055-4061.
Kaley TJ, DeAngelis LM. Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol. 2009;145:3-14.
Maloney KW. Nursing Management of Chemotherapy-Induced Peripheral Neuropathy - Continuing Education, 10/4/09. Oncolink Web site. Accessed at www.oncolink.org/resources/article1.cfm?id=1010 on March 1, 2013.
National Cancer Center Network, NCCN Clinical Practice Guidelines in Oncology™. Adult Cancer Pain, v. 1.2013. Accessed at www.nccn.org/professionals/physician_gls/pdf/pain.pdf on March 1, 2013.
Paice JA. Clinical challenges: chemotherapy-induced peripheral neuropathy. Semin Oncol Nurs. 2009;25(2 Suppl 1):S8-S19.
Richardson PG, Xie W, Mitsiades C, Chanan-Khan AA, et al. Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol. 2009;27:3518-3525.
Stubblefield MD, McNeely ML, Alfano CM, Mayer DK. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Cancer. 2012;118(8 Suppl):2250-2260.
Tournigand C. OPTIMOX1: A randomized study of FOLFOX4 or FOLFOX7 in a stop-and-go fashion in advanced colorectal cancer–A GERCOR study. J Clin Oncol. 2006;24:394-400.
Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C. Putting evidence into practice: Evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs. 2007;11:901-913.
Wickham R. Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clin J Oncol Nurs. 2007;11:361-376.
Last Medical Review: 03/08/2013
Last Revised: 04/02/2013